Literature DB >> 2466221

Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children.

J M Launay1, P Ferrari, M Haimart, C Bursztejn, F Tabuteau, A Braconnier, D Pasques-Bondoux, C Luong, C Dreux.   

Abstract

The serotonin metabolism was extensively studied in 22 couples of autistic children and age- and sex-matched controls. Histamine, calcium, and uric acid were also measured in urine and whole blood or plasma. Autistics and controls did not differ in histamine, and only minor changes were noticed in calcium content. According to previous reports, serotonin levels were often, but not always, elevated in the blood of autistic children. Based on data including urinary serotonin and 5-hydroxyindoleacetic acid, platelet serotonin uptake and efflux, platelet monoamine oxidase and glutathione peroxidase activities, and uric acid and plasma tryptophan, the origin(s) of such hyperserotonemia in autism appear(s) to be of metabolic origin, i.e., a decreased catabolism and/or an increased biosynthesis of serotonin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466221     DOI: 10.1159/000118465

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

1.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

2.  Childhood autism: An appeal for an integrative and psychobiological approach.

Authors:  Robert D Oades; Christian Eggers
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-07       Impact factor: 4.785

3.  Brief report: Platelet-poor plasma serotonin in autism.

Authors:  George M Anderson; Margaret E Hertzig; P A McBride
Journal:  J Autism Dev Disord       Date:  2012-07

4.  Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.

Authors:  E H Cook; B D Perry; G Dawson; M S Wainwright; B L Leventhal
Journal:  J Autism Dev Disord       Date:  1993-03

5.  Hyperserotonemia in autism: activity of 5HT-associated platelet proteins.

Authors:  Dubravka Hranilović; Zorana Bujas-Petković; Maja Tomicić; Tatjana Bordukalo-Niksić; Sofia Blazević; Lipa Cicin-Sain
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

6.  Statistical distribution of blood serotonin as a predictor of early autistic brain abnormalities.

Authors:  Skirmantas Janusonis
Journal:  Theor Biol Med Model       Date:  2005-07-19       Impact factor: 2.432

7.  Histaminergic system in brain disorders: lessons from the translational approach and future perspectives.

Authors:  Diego Baronio; Taylor Gonchoroski; Kamila Castro; Geancarlo Zanatta; Carmem Gottfried; Rudimar Riesgo
Journal:  Ann Gen Psychiatry       Date:  2014-11-18       Impact factor: 3.455

8.  Heritability of the melatonin synthesis variability in autism spectrum disorders.

Authors:  Marion Benabou; Thomas Rolland; Claire S Leblond; Gaël A Millot; Guillaume Huguet; Richard Delorme; Marion Leboyer; Cécile Pagan; Jacques Callebert; Erik Maronde; Thomas Bourgeron
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

9.  Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.

Authors:  Cécile Pagan; Marion Benabou; Claire Leblond; Freddy Cliquet; Alexandre Mathieu; Nathalie Lemière; Hany Goubran-Botros; Richard Delorme; Marion Leboyer; Jacques Callebert; Thomas Bourgeron; Jean-Marie Launay
Journal:  Transl Psychiatry       Date:  2021-01-07       Impact factor: 6.222

10.  Cadherin-13 Deficiency Increases Dorsal Raphe 5-HT Neuron Density and Prefrontal Cortex Innervation in the Mouse Brain.

Authors:  Andrea Forero; Olga Rivero; Sina Wäldchen; Hsing-Ping Ku; Dominik P Kiser; Yvonne Gärtner; Laura S Pennington; Jonas Waider; Patricia Gaspar; Charline Jansch; Frank Edenhofer; Thérèse J Resink; Robert Blum; Markus Sauer; Klaus-Peter Lesch
Journal:  Front Cell Neurosci       Date:  2017-09-26       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.